Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-04

Clinical Trial Update: Effectiveness of the Diaphragm for HIV Prevention [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effectiveness of the diaphragm for HIV prevention has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: HIV Infection | Phase 3 | Status: WITHDRAWN